Led by Chair Dr Daniel Karlin of Pfizer, Mobile in Clinical Trials Europe opens with a session given by Tilo Hache, Novartis, on the factors that must be addressed to implement mobile tools in the fragmented European landscape and to meet the needs of regulators and patients. Additional sessions:
- Roche's Dr Christian Gossens discusses digital biomarker measures and how to implement and scale up mobile technology in Parkinson's disease and Multiple Sclerosis.
- UCSF's Carol Maguire shares the obstacles and challenges of their ongoing revolutionary mobile clinical study, including strategies for integrating multiple digital components in a study.
- Vodafone's Dr Nuria Oliver gives a visionary AI keynote on data driven decision-making.
- Clinical Trial Transformation Initiative's Jen Goldsack presents recommendations on novel endpoints following a three-year global study on data generated from mobile technology.
Other topics to be addressed:
- Real-time implementation of mobile solutions
- Trials driving efficiency
- Perceived barriers and how to overcome them
- Moving past the hype of mhealth and producing evidence
- Mobile 2.0, wearable, sensors, apps and mobile devices
The speaking faculty includes:
- Emma Bender, Marketing Manager, NIHR
- Jennifer Goldsack, MChem, MA, MBA, CPHQ, Clinical Project Manager, CTTI
- Christian Gossens, PhD, MBA, Global Head Early Development Workflows, pRED, Informatics, Roche Pharmaceutical Research and Early Development (pRED)
- Bert Hartog, PhD, Senior Director, Clinical Innovation, RandD Operations, Janssen
- Carol Maguire, RN, Director of Clinical Research, Division of Cardiology, UCSF
- Nuria Oliver, PhD, Director of Research in Data Science, Vodafone
- Tushar Parlikar, PhD, Product Manager, Verily Life Sciences
- Barry Pinnington, Patient Advocate
- Hilde Vanaken, PhD, Director, RandD Operations Innovation, Janssen
- Roche's Dr Christian Gossens discusses digital biomarker measures and how to implement and scale up mobile technology in Parkinson's disease and Multiple Sclerosis.
- UCSF's Carol Maguire shares the obstacles and challenges of their ongoing revolutionary mobile clinical study, including strategies for integrating multiple digital components in a study.
- Vodafone's Dr Nuria Oliver gives a visionary AI keynote on data driven decision-making.
- Clinical Trial Transformation Initiative's Jen Goldsack presents recommendations on novel endpoints following a three-year global study on data generated from mobile technology.
Other topics to be addressed:
- Real-time implementation of mobile solutions
- Trials driving efficiency
- Perceived barriers and how to overcome them
- Moving past the hype of mhealth and producing evidence
- Mobile 2.0, wearable, sensors, apps and mobile devices
The speaking faculty includes:
- Emma Bender, Marketing Manager, NIHR
- Jennifer Goldsack, MChem, MA, MBA, CPHQ, Clinical Project Manager, CTTI
- Christian Gossens, PhD, MBA, Global Head Early Development Workflows, pRED, Informatics, Roche Pharmaceutical Research and Early Development (pRED)
- Bert Hartog, PhD, Senior Director, Clinical Innovation, RandD Operations, Janssen
- Carol Maguire, RN, Director of Clinical Research, Division of Cardiology, UCSF
- Nuria Oliver, PhD, Director of Research in Data Science, Vodafone
- Tushar Parlikar, PhD, Product Manager, Verily Life Sciences
- Barry Pinnington, Patient Advocate
- Hilde Vanaken, PhD, Director, RandD Operations Innovation, Janssen
